J. Delzer

A fluorescence-based in vitro assay for drug interactions with breast cancer resistance protein (BCRP, ABCG2).

G. Fricker, Anne Mahringer, J. Delzer, 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Design and synthesis of 1,5- and 2,5-substituted tetrahydrobenzazepinones as novel potent and selective integrin α V β 3 antagonists

A. Kling, J. Delzer, Udo E W Lange, 2003 .

Highly potent and selective αVβ3-receptor antagonists: solid-phase synthesis and SAR of 1-substituted 4-amino-1H-pyrimidin-2-ones

A. Kling, J. Delzer, C. Zechel, 2003 .

Synthesis and SAR of N-substituted dibenzazepinone derivatives as novel potent and selective αVβ3 antagonists

A. Kling, J. Delzer, Udo E W Lange, 2002 .

Synthesis of highly potent and selective hetaryl ureas as integrin αVβ3-Receptor antagonists

A. Kling, J. Delzer, C. Zechel, 2002 .

Synthesis and SAR of highly potent and selective dopamine D3-receptor antagonists: 1H-Pyrimidin-2-one derivatives

A. Kling, L. Unger, W. Wernet, 2006 .

Design and synthesis of novel potent and selective integrin αvβ3 antagonists—Novel synthetic routes to isoquinolinone, benzoxazinone, and quinazolinone acetates

Werner Seitz, A. Kling, Thomas Subkowski, 2008 .

Synthesis and SAR of highly potent and selective dopamine D3-receptor antagonists: Quinolin(di)one and benzazepin(di)one derivatives

L. Unger, W. Wernet, C. Hutchins, 2006 .

Genomic Knockout of Endogenous Canine P-Glycoprotein in Wild-Type, Human P-Glycoprotein and Human BCRP Transfected MDCKII Cell Lines by Zinc Finger Nucleases

J. Sydor, T. Terasaki, G. Fricker, 2015, Pharmaceutical Research.

Synthesis and SAR of highly potent and selective dopamine D3-receptor antagonists: variations on the 1H-pyrimidin-2-one theme.

L. Unger, W. Wernet, D. Sauer, 2006, Bioorganic & medicinal chemistry letters.